Headline

The latest stories from AHA Today.

The Health Resources and Services Administration awarded states, territories and nonprofit organizations $341 million in fiscal year 2020 funding for the Maternal, Infant and Early Childhood Home Visiting Program, which provides voluntary home visiting services to pregnant women and parents with…
AHA General Counsel Melinda Hatton interviews Cate Stetson, acclaimed advocate and leader of the appellate practice at Hogan Lovells, about the U.S. Supreme Court vacancy and what it means for the legal challenges facing the Affordable Care Act and other legal cases that matter to hospitals and…
The House approved by voice vote the Competitive Health Insurance Reform Act, AHA-supported legislation that would repeal the antitrust exemption available to commercial health insurers for anticompetitive conduct.
The House of Representatives passed the Maternal Health Quality Improvement Act of 2019 (H.R. 4995), which would create new Public Health Service Act programs to improve maternal health.
Molly Smith, AHA vice president for coverage and state issues forum, participated in a panel discussion on reducing health care costs in the U.S. health care system without sacrificing quality, as part of The Atlantic Festival’s virtual event.
Nearly 30 representatives urged House leaders to modify in the next COVID-19 response package impending thresholds for qualifying participants in Advanced Alternative Payment Models, which they said threaten to “derail” the movement to value-based care under the Medicare Access and CHIP…
The U.S. death toll from COVID-19 today surpassed 200,000, according to the Coronavirus Resource Center at Johns Hopkins University & Medicine.
The AHA is accepting applications through Nov. 23 for its 2021 Dick Davidson NOVA Award, which recognizes outstanding collaboration by hospitals and health systems for healthier communities.
The Health Resources and Services Administration released a final rule and notice expanding the types of expenses the National Living Donor Assistance Center will reimburse to include lost wages and child- and elder-care expenses for living donors who lack other forms of financial support.
The Food and Drug Administration reissued its emergency use authorization for the Abbott ID NOW COVID-19 test to indicate that the product is intended for specimens collected “from individuals who are suspected of COVID-19 by their health care provider within the first seven days of the onset of…